Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2012
08/30/2012US20120219524 Antibodies that bind colony stimulating factor 1 receptor (csf1r)
08/30/2012US20120219523 Method of treating tuberculosis with interferons
08/30/2012US20120219522 Substituted quinoline compounds and methods of use
08/30/2012US20120219514 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
08/30/2012US20120219506 Catenae: Serosal Cancer Stem Cells
08/30/2012US20120219505 Peptide reagents and methods for detection of colon dysplasia
08/30/2012US20120219504 Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof
08/30/2012US20120219502 Methods and compositions for targeting gc1qr/p32
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012US20120219497 Random ethylene oxide and non-random alkylene oxide(s) polymers
08/30/2012CA2828255A1 Protein nanocarriers for topical delivery
08/30/2012CA2828229A1 Recombinant mumps virus vaccine
08/30/2012CA2828122A1 Cancer diagnosis and treatment
08/30/2012CA2827990A1 Chalcone derivatives as nrf2 activators
08/30/2012CA2827329A1 Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes
08/30/2012CA2827187A1 Water soluble membrane proteins and methods for the preparation and use thereof
08/30/2012CA2824497A1 Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
08/29/2012EP2492278A1 Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy
08/29/2012EP2491944A2 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
08/29/2012EP2491943A2 Methods for preventing mitochondrial permeability transition
08/29/2012EP2491942A1 Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
08/29/2012EP2491941A1 Organ preservation and/or perfusion
08/29/2012EP2491940A2 Method for inducing cytotoxic T-cells, cytotoxic T-cell inducer, and pharmaceutical composition and vaccine employing same
08/29/2012EP2491928A2 Therapeutic agent for vitiligo and method of accelerating pigmentation
08/29/2012EP2491926A1 Treatment of protein degradation disorders
08/29/2012EP2491143A2 Methods and compositions for diagnosis and treatment of genetic and retinal disease
08/29/2012EP2491114A1 Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
08/29/2012EP2491052A2 Oxytocin receptor agonists
08/29/2012EP2490766A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
08/29/2012EP2490724A2 Compositions for improving migration potential of stem cells
08/29/2012EP2490712A1 Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases
08/29/2012EP2490711A1 A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
08/29/2012EP2490710A2 Treatment of pre-term neonates
08/29/2012EP2490709A1 Peptidic glp-2 agonists
08/29/2012EP2490708A2 Stabilized glucagon solutions
08/29/2012EP2490707A2 Medical utility of glycan-binding proteins and glycans
08/29/2012EP2490706A2 Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
08/29/2012EP2490701A2 Cardiomyocyte production
08/29/2012EP2008664B1 Modified proteins which bind extracellular matrix components
08/29/2012CN1924021B Gene recombination humanized pigment epithelium derivative factor and application therof
08/29/2012CN1889974B Oligopeptides as coating material for medical products
08/29/2012CN1886151B Pharmaceutical formulations for the sustained release of oneor more active principles and applications thereof, such as therapeutic applications
08/29/2012CN1841066B Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/29/2012CN1826130B Use of a PAK inhibitor for the treatment of a joint disease
08/29/2012CN1820782B Thyroid hormone medicinal preparation and its preparing method
08/29/2012CN1735435B Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same
08/29/2012CN1636594B Angiostatin and use of the same for inhibition of angiogenesis
08/29/2012CN102652021A Prophylactic agent for atopic dermatitis
08/29/2012CN102652020A Combination preparations comprising exosomes and corticosteroid
08/29/2012CN102652015A Pharmaceutical composition comprising oligopeptides
08/29/2012CN102649978A Application of CCDC158 gene in preparation of drugs for treating or diagnosing liver cancer
08/29/2012CN102649814A Earthworm protein with HBeAg degrading enzyme activity and application thereof
08/29/2012CN102649810A Camptothecin derivative and preparation method and application thereof
08/29/2012CN102649809A Preparation method for diamino PEG (Poly Ethylene Glycol)-antibacterial peptide
08/29/2012CN102648978A Stable protein pharmaceutical preparation and preparation method thereof
08/29/2012CN102648977A Application of follistatin-related protein 1 in adjusting Na, K-ATPase activity
08/29/2012CN102648917A Application of vitamin D3 in preparing medicine for treating multiple myeloma
08/29/2012CN102212109B Bone polypeptide compound separated from ossotide injection and application thereof
08/29/2012CN102210783B Composition preparation of donkey-hide glue, and preparation method thereof
08/29/2012CN102180973B Target multifunctional anti-embolism fusion protein as well as preparation method and application thereof
08/29/2012CN102178679B Application of pyrroloquinoline quinone to the bone marrow hemopoietic function after recovery of radiation
08/29/2012CN102125178B Feed additive for preventing and treating virus caused death of aquatic livestock and preparation method thereof
08/29/2012CN102038935B Application of Cucurmosin in preparation of medicaments for treating cervical cancer
08/29/2012CN102038934B Application of cucurmosin in preparation of drug for treating breast cancer
08/29/2012CN102028672B Microporous spongy film preparation and preparation method thereof
08/29/2012CN102020698B Hepatitis c virus protease inhibitor
08/29/2012CN101947206B Method for preparing recombinant pancreotropic hormone secretion peptide medicament microspheres
08/29/2012CN101912601B Stabilised solid compositions of factor VII polypeptides
08/29/2012CN101631854B Laccases for pulp bio-bleaching
08/29/2012CN101616657B Whitening agent
08/29/2012CN101559076B Anti-tumor-stroma metalloprotease inhibitor
08/29/2012CN101516390B Agent for preventing development of reflex sympathetic dystrophy after stroke
08/29/2012CN101429232B Hcv protease inhibitors
08/29/2012CN101426807B Neuroprotective compounds and uses thereof
08/29/2012CN101400363B Pharmaceutical compositions with enhanced stability
08/29/2012CN101318019B Compositions and methods for the therapy of inflammatory bowel disease
08/29/2012CN101272690B Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof
08/29/2012CN101108878B Glp-1 analogues
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252918 RNAi probes targeting cancer-related proteins
08/28/2012US8252915 Human transferase family members and uses thereof
08/28/2012US8252908 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
08/28/2012US8252907 Methods and compositions for inhibiting binding of IgE to a high affinity receptor
08/28/2012US8252896 Process for making bivalirudin
08/28/2012US8252893 CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
08/28/2012US8252846 Strategies for delivery of active agents using micelles and particles
08/28/2012US8252845 Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform
08/28/2012US8252765 Treatment of cancer by inhibition of IGFBPs and clusterin
08/28/2012US8252764 Compositions and methods of use of targeting peptides against placenta and adipose tissues
08/28/2012US8252749 Methods, kits, and compositions for generating new hair follicles and growing hair
08/28/2012US8252748 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
08/28/2012US8252747 Tissue adhesive sealant
08/28/2012US8252746 Anti-angiogenic agents and methods of their use
08/28/2012US8252745 Methods for treatment of headaches by administration of oxytocin
08/28/2012US8252744 Implantable pump for protein delivery for obesity control by drug infusion into the brain
08/28/2012US8252743 Modified erythropoietin polypeptides and uses thereof for treatment
08/28/2012US8252742 Methods for enhancing the quality of life of a senior animal
08/28/2012US8252741 Uses of modified ELR-CXC chemokine G31P
08/28/2012US8252740 Thermally-targeted delivery of medicaments including doxorubicin
1 ... 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 ... 3163